Introduction to Using Clinically Validated Variants In Assessing Ngs Technologies
Let's dive into the details surrounding Using Clinically Validated Variants In Assessing Ngs Technologies. Eunice Lee, Ph.D., Branch Chief, Division of Molecular Genetics and Pathology, OIR/CDRH/FDA.
Using Clinically Validated Variants In Assessing Ngs Technologies Comprehensive Overview
In this webcast, Gabe Rudy, Vice President of Product Development, will showcase publicly available databases and resources ... You Li, Ph.D., Reviewer, Division of Molecular Genetics and Pathology, OIR/CDRH/FDA. Download the free Sanger sequencing handbook at http://www.thermofisher.com/sangerhandbook To learn more about the
Next generation sequencing
Summary & Highlights for Using Clinically Validated Variants In Assessing Ngs Technologies
- NGS
- Albert Ferran finished his MSc in Genetic Anthropology in 2011 and worked as a research scientist at The University of Barcelona ...
- Speaker: Dr. Florian Battke | CeGaT Management Presented at: Tricon 2022.
- Next generation sequencing
- The Green Park Collaborative (GPC) hosted a webinar on the College of American Pathologists' (CAP) Accreditation Program for ...
That wraps up our extensive overview of Using Clinically Validated Variants In Assessing Ngs Technologies.